Ambit Biosciences Corp Watch

from 8-K 18 pages Contingent Value Rights Agreement

from SC TO-C 18 pages Contingent Value Rights Agreement

from SC TO-C 11 pages Tender Agreement

from 8-K 11 pages Tender Agreement

from 8-K 109 pages Agreement and Plan of Merger Among: Ambit Biosciences Corporation, a Delaware Corporation; Daiichi Sankyo Company, Limited, a Japanese Corporation; and Charge Acquisition Corp., a Delaware Corporation Dated as of September 28, 2014

from SC TO-C 109 pages Agreement and Plan of Merger Among: Ambit Biosciences Corporation, a Delaware Corporation; Daiichi Sankyo Company, Limited, a Japanese Corporation; and Charge Acquisition Corp., a Delaware Corporation Dated as of September 28, 2014

from S-1 4 pages October 21, 2010 Pyare Khanna, CEO Discoverx Corporation 42501 Albrae Street Fremont, Ca 94538 Re: Asset Purchase Agreement Dear Pyare, This Letter Shall Serve as an Amendment to the Asset Purchase Agreement (“Agreement”) Entered Into by and Between Discoverx and Ambit for the Sale of Ambit’s Kinomescan Business, as We Previous Discussed. Below Are the Amendments Referenced to the Sections of the Agreement. Section 3.9

from S-1 43 pages Asset Purchase Agreement Acquisition of Certain Assets of Ambit Biosciences Corporation by Discoverx Corporation Dated as of October 21, 2010